Phéochromocytome et paragangliome
Phaeochromocytomas and paragangliomas (PPGL) are rare neuroendocrine tumors that arise from the adrenal medulla or sympathetic and parasympathetic ganglia. These tumors produce most often catecholamines in excess, causing hypertension and sometimes severe acute cardiovascular complications. The diag...
Gespeichert in:
Veröffentlicht in: | La revue de medecine interne 2019-11, Vol.40, p.733-741 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 741 |
---|---|
container_issue | |
container_start_page | 733 |
container_title | La revue de medecine interne |
container_volume | 40 |
creator | Cornu, E. Belmihoub, I. Burnichon, N. Grataloup, C. Zinzindohoué, F. Baron, S. Billaud, E. Azizi, M. Gimenez-Roqueplo, A.-P. Amar, L. |
description | Phaeochromocytomas and paragangliomas (PPGL) are rare neuroendocrine tumors that arise from the adrenal medulla or sympathetic and parasympathetic ganglia. These tumors produce most often catecholamines in excess, causing hypertension and sometimes severe acute cardiovascular complications. The diagnosis is based on plasma or urines metanephrines measurements and on conventional and nuclear medicine imaging. Catecholamines-producing PPGL is very unlikely if levels are normal. The diagnosis of PPGL cannot be made without visualization of a tumor. Therapeutic management consists mostly of surgical excision, after drug preparation, and should be done in referral centers. About 40% of pheochromocytomas and paragangliomas occur in the context of an autosomal inherited syndrome, making genetic testing essential. The follow-up must be prolonged because a metastatic evolution or a recurrence can be observed in about 15% of the cases. |
doi_str_mv | 10.1016/j.revmed.2019.07.008 |
format | Article |
fullrecord | <record><control><sourceid>hal</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_03488668v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>oai_HAL_hal_03488668v1</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1318-23372dc371caae4affb98cf305b6b2f33328203411766ed066664fa50036aa663</originalsourceid><addsrcrecordid>eNotj0FLw0AUhBdRbKz-Aw_Fm4es7-3bbjbHUtQKAT3oObxsdpuUxJSkFPqT_B3-MVd0LgMD3zAjxC2CREDzsJOjP_a-lgowl5BJAHsmEsyMTQmVOhcJKG1TawzNxNU07QAgkvmlmBHqnHKyibh7a76_BteMQz-402Ho_cIfFnseecuf266NwbW4CNxN_ubf5-Lj6fF9vUmL1-eX9apIHRLaVBFlqnaUoWP2mkOocusCwbIylQpEpKwC0hgXGl-DidKBlwBkmOPIubj_6224K_dj2_N4Kgduy82qKH-zCNv4xh6RfgAM3kXv</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Phéochromocytome et paragangliome</title><source>Access via ScienceDirect (Elsevier)</source><creator>Cornu, E. ; Belmihoub, I. ; Burnichon, N. ; Grataloup, C. ; Zinzindohoué, F. ; Baron, S. ; Billaud, E. ; Azizi, M. ; Gimenez-Roqueplo, A.-P. ; Amar, L.</creator><creatorcontrib>Cornu, E. ; Belmihoub, I. ; Burnichon, N. ; Grataloup, C. ; Zinzindohoué, F. ; Baron, S. ; Billaud, E. ; Azizi, M. ; Gimenez-Roqueplo, A.-P. ; Amar, L.</creatorcontrib><description>Phaeochromocytomas and paragangliomas (PPGL) are rare neuroendocrine tumors that arise from the adrenal medulla or sympathetic and parasympathetic ganglia. These tumors produce most often catecholamines in excess, causing hypertension and sometimes severe acute cardiovascular complications. The diagnosis is based on plasma or urines metanephrines measurements and on conventional and nuclear medicine imaging. Catecholamines-producing PPGL is very unlikely if levels are normal. The diagnosis of PPGL cannot be made without visualization of a tumor. Therapeutic management consists mostly of surgical excision, after drug preparation, and should be done in referral centers. About 40% of pheochromocytomas and paragangliomas occur in the context of an autosomal inherited syndrome, making genetic testing essential. The follow-up must be prolonged because a metastatic evolution or a recurrence can be observed in about 15% of the cases.</description><identifier>ISSN: 0248-8663</identifier><identifier>EISSN: 1768-3122</identifier><identifier>DOI: 10.1016/j.revmed.2019.07.008</identifier><identifier>PMID: 31493938</identifier><language>eng</language><publisher>Elsevier</publisher><subject>Life Sciences</subject><ispartof>La revue de medecine interne, 2019-11, Vol.40, p.733-741</ispartof><rights>Attribution - NonCommercial</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1318-23372dc371caae4affb98cf305b6b2f33328203411766ed066664fa50036aa663</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://hal.science/hal-03488668$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Cornu, E.</creatorcontrib><creatorcontrib>Belmihoub, I.</creatorcontrib><creatorcontrib>Burnichon, N.</creatorcontrib><creatorcontrib>Grataloup, C.</creatorcontrib><creatorcontrib>Zinzindohoué, F.</creatorcontrib><creatorcontrib>Baron, S.</creatorcontrib><creatorcontrib>Billaud, E.</creatorcontrib><creatorcontrib>Azizi, M.</creatorcontrib><creatorcontrib>Gimenez-Roqueplo, A.-P.</creatorcontrib><creatorcontrib>Amar, L.</creatorcontrib><title>Phéochromocytome et paragangliome</title><title>La revue de medecine interne</title><description>Phaeochromocytomas and paragangliomas (PPGL) are rare neuroendocrine tumors that arise from the adrenal medulla or sympathetic and parasympathetic ganglia. These tumors produce most often catecholamines in excess, causing hypertension and sometimes severe acute cardiovascular complications. The diagnosis is based on plasma or urines metanephrines measurements and on conventional and nuclear medicine imaging. Catecholamines-producing PPGL is very unlikely if levels are normal. The diagnosis of PPGL cannot be made without visualization of a tumor. Therapeutic management consists mostly of surgical excision, after drug preparation, and should be done in referral centers. About 40% of pheochromocytomas and paragangliomas occur in the context of an autosomal inherited syndrome, making genetic testing essential. The follow-up must be prolonged because a metastatic evolution or a recurrence can be observed in about 15% of the cases.</description><subject>Life Sciences</subject><issn>0248-8663</issn><issn>1768-3122</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNotj0FLw0AUhBdRbKz-Aw_Fm4es7-3bbjbHUtQKAT3oObxsdpuUxJSkFPqT_B3-MVd0LgMD3zAjxC2CREDzsJOjP_a-lgowl5BJAHsmEsyMTQmVOhcJKG1TawzNxNU07QAgkvmlmBHqnHKyibh7a76_BteMQz-402Ho_cIfFnseecuf266NwbW4CNxN_ubf5-Lj6fF9vUmL1-eX9apIHRLaVBFlqnaUoWP2mkOocusCwbIylQpEpKwC0hgXGl-DidKBlwBkmOPIubj_6224K_dj2_N4Kgduy82qKH-zCNv4xh6RfgAM3kXv</recordid><startdate>20191130</startdate><enddate>20191130</enddate><creator>Cornu, E.</creator><creator>Belmihoub, I.</creator><creator>Burnichon, N.</creator><creator>Grataloup, C.</creator><creator>Zinzindohoué, F.</creator><creator>Baron, S.</creator><creator>Billaud, E.</creator><creator>Azizi, M.</creator><creator>Gimenez-Roqueplo, A.-P.</creator><creator>Amar, L.</creator><general>Elsevier</general><scope>1XC</scope><scope>VOOES</scope></search><sort><creationdate>20191130</creationdate><title>Phéochromocytome et paragangliome</title><author>Cornu, E. ; Belmihoub, I. ; Burnichon, N. ; Grataloup, C. ; Zinzindohoué, F. ; Baron, S. ; Billaud, E. ; Azizi, M. ; Gimenez-Roqueplo, A.-P. ; Amar, L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1318-23372dc371caae4affb98cf305b6b2f33328203411766ed066664fa50036aa663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Life Sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cornu, E.</creatorcontrib><creatorcontrib>Belmihoub, I.</creatorcontrib><creatorcontrib>Burnichon, N.</creatorcontrib><creatorcontrib>Grataloup, C.</creatorcontrib><creatorcontrib>Zinzindohoué, F.</creatorcontrib><creatorcontrib>Baron, S.</creatorcontrib><creatorcontrib>Billaud, E.</creatorcontrib><creatorcontrib>Azizi, M.</creatorcontrib><creatorcontrib>Gimenez-Roqueplo, A.-P.</creatorcontrib><creatorcontrib>Amar, L.</creatorcontrib><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>La revue de medecine interne</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cornu, E.</au><au>Belmihoub, I.</au><au>Burnichon, N.</au><au>Grataloup, C.</au><au>Zinzindohoué, F.</au><au>Baron, S.</au><au>Billaud, E.</au><au>Azizi, M.</au><au>Gimenez-Roqueplo, A.-P.</au><au>Amar, L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phéochromocytome et paragangliome</atitle><jtitle>La revue de medecine interne</jtitle><date>2019-11-30</date><risdate>2019</risdate><volume>40</volume><spage>733</spage><epage>741</epage><pages>733-741</pages><issn>0248-8663</issn><eissn>1768-3122</eissn><abstract>Phaeochromocytomas and paragangliomas (PPGL) are rare neuroendocrine tumors that arise from the adrenal medulla or sympathetic and parasympathetic ganglia. These tumors produce most often catecholamines in excess, causing hypertension and sometimes severe acute cardiovascular complications. The diagnosis is based on plasma or urines metanephrines measurements and on conventional and nuclear medicine imaging. Catecholamines-producing PPGL is very unlikely if levels are normal. The diagnosis of PPGL cannot be made without visualization of a tumor. Therapeutic management consists mostly of surgical excision, after drug preparation, and should be done in referral centers. About 40% of pheochromocytomas and paragangliomas occur in the context of an autosomal inherited syndrome, making genetic testing essential. The follow-up must be prolonged because a metastatic evolution or a recurrence can be observed in about 15% of the cases.</abstract><pub>Elsevier</pub><pmid>31493938</pmid><doi>10.1016/j.revmed.2019.07.008</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0248-8663 |
ispartof | La revue de medecine interne, 2019-11, Vol.40, p.733-741 |
issn | 0248-8663 1768-3122 |
language | eng |
recordid | cdi_hal_primary_oai_HAL_hal_03488668v1 |
source | Access via ScienceDirect (Elsevier) |
subjects | Life Sciences |
title | Phéochromocytome et paragangliome |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T04%3A03%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-hal&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ph%C3%A9ochromocytome%20et%20paragangliome&rft.jtitle=La%20revue%20de%20medecine%20interne&rft.au=Cornu,%20E.&rft.date=2019-11-30&rft.volume=40&rft.spage=733&rft.epage=741&rft.pages=733-741&rft.issn=0248-8663&rft.eissn=1768-3122&rft_id=info:doi/10.1016/j.revmed.2019.07.008&rft_dat=%3Chal%3Eoai_HAL_hal_03488668v1%3C/hal%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/31493938&rfr_iscdi=true |